N-(4-(Benzyloxy)phenyl)-2-cyanoacetamide

Catalog No. :
ACRPAE319
CAS No. :
524036-03-1
Molecular Formula :
C16H14N2O2
Molecular Weight :
266.30

IUPAC Name:N-(4-(benzyloxy)phenyl)-2-cyanoacetamide

N-(4-(Benzyloxy)phenyl)-2-cyanoacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$128.00Login to see priceIn stockInquiry
250mg98%$217.00Login to see priceIn stockIn stock
1g98%$304.00Login to see priceIn stockIn stock
5g98%$394.00Login to see priceIn stockInquiry
25g98%$1721.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-(Benzyloxy)phenyl)-2-cyanoacetamide
IUPAC NameN-(4-(benzyloxy)phenyl)-2-cyanoacetamide
MDL No.MFCD03410226
Molecular FormulaC16H14N2O2
Molecular Weight266.30
SMILESO=C(NC1=CC=C(OCC2=CC=CC=C2)C=C1)CC#N
InChI KeyFBDKGXHHEYEDJH-UHFFFAOYSA-N
Synonym{N}-[4-(benzyloxy)phenyl]-2-cyanoacetamide;Acetamide, 2-cyano-N-[4-(phenylmethoxy)phenyl]-
CAS No.524036-03-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACRPAE319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMCAP915 route compound structure diagram
    ACMCAP9151071-36-9 In Stock
  2. Plus
  3. ACNLPY920 route compound structure diagram
    ACNLPY9206373-46-2 In Stock
  4. Then
  5. ACRPAE319 route product structure diagram
    ACRPAE319524036-03-1 In Stock
Inquiry

2. ACRPAE319 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNLPY920 route compound structure diagram
    ACNLPY9206373-46-2 In Stock
  4. Then
  5. ACRPAE319 route product structure diagram
    ACRPAE319524036-03-1 In Stock
Inquiry

Comments (0)